University of California San Francisco

Publications

  1. ASO Author Reflections: Changes in Primary Treatment Strategy for Invasive Lobular Carcinoma Highlight the Need for Better Predictors of Therapy Response.
    Mukhtar RA, Boughey JC
    Ann Surg Oncol. 2021 10; 28(11):5878-5879.; 
    PubMed
  2. Applications of 3D printing in breast cancer management.
    Galstyan A, Bunker MJ, Lobo F, Sims R, Inziello J, Stubbs J, Mukhtar R, Kelil T
    3D Print Med. 2021 Feb 09; 7(1):6.; 
    PubMed
  3. Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy.
    Jones EF, Hathi DK, Freimanis R, Mukhtar RA, Chien AJ, Esserman LJ, Van't Veer LJ, Joe BN, Hylton NM
    Cancers (Basel). 2020 Jun 09; 12(6).; 
    PubMed
  4. UCSF Research Profile ">Abstract P6-16-06: Improved early stratification of invasive cancer risk using MRI in a ductal carcinoma in-situ short-term active surveillance cohort treated with neoadjuvant endocrine therapy.
    Paul Kim, Heather I. Greenwood, Rita I. Freimanis, Gillian L Hirst, Megan Fischer-Colbrie, Jessica Gibbs, Nola M Hylton, Christina Yau, Eun-Sil Shelley Hwang, Laura J. Esserman, Rita A Mukhtar
    Cancer Research. 2020 Feb 15; 80(4_Supplement):p6-16-06-p6-16-06.; 
    UCSF Research Profile ">UCSF Research Profile
  5. Synchronous Breast Implant-associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications.
    Mukhtar RA, Holland M, Sieber DA, Wen KW, Rugo HS, Kadin ME, Bean GR
    Plast Reconstr Surg Glob Open. 2019 Apr; 7(4):e2188.; 
    PubMed
  6. Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents.
    Tang V, Zhao S, Boscardin J, Sudore R, Covinsky K, Walter LC, Esserman L, Mukhtar R, Finlayson E
    JAMA Surg. 2018 12 01; 153(12):1090-1096.; 
    PubMed
  7. UCSF Research Profile ">Breast tumor location in BRCA mutation carriers and implications for prevention.
    Ava Hosseini, Laura Esserman, Anne M. Wallace, Amal Khoury, Alfred Au, Rita Mukhtar
    Journal of Clinical Oncology. 2017 May 20; 35(15_suppl):e13048-e13048.; 
    UCSF Research Profile ">UCSF Research Profile
  8. Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
    Mukhtar RA, Yau C, Rosen M, Tandon VJ, I-SPY 1 TRIAL and ACRIN 6657 Investigators, Hylton N, Esserman LJ
    Ann Surg Oncol. 2013 Nov; 20(12):3823-30.; 
    PubMed
  9. UCSF Research Profile ">Identification of pathogenic macrophages in breast cancer as markers of tumor aggressiveness.
    R. Mukhtar, A. P. Moore, V. Tandon, O. Nseyo, A. Au, F. L. Baehner, C. A. Adisa, N. Eleweke, O. I. Olopade, D. H. Moore, M. Campbell, L. Esserman
    Journal of Clinical Oncology. 2011 May 20; 29(15_suppl):1043-1043.; 
    UCSF Research Profile ">UCSF Research Profile
  10. Variation in annual volume at a university hospital does not predict mortality for pancreatic resections.
    Mukhtar RA, Kattan OM, Harris HW
    HPB Surg. 2008; 2008:190914.; 
    PubMed
  11. ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.
    Tseng J, Dimitroff K, Sauder CAM, Chien AJ, Ahmed KA, Allen LF, Arciero CA, Burke EE, Chandler JM, Jordan JE, Golshan M, Gutnik LA, Jaskowiak NT, Hewitt KC, Howard-McNatt M, Ito F, Kang IM, Kesmodel SB, Kuerrer HM, Lee MC, Moran MS, Postlewait LM, Prionas ND, Rao R, Reyna CR, Schwer A, Taunk NK, Tchou J, Wallace AM, Li TJ, Perlmutter J, DeMichele AM, Yee D, Hylton NM, Van't Veer LJ, Rugo HS, Symmans WF, Shatsky RA, Isaacs CJD, Yau C, Esserman LJ, Boughey JC, Mukhtar RA
    Ann Surg Oncol. 2026 Oct; 33(11):9659-9660.; 
    PubMed
  12. Characteristics of Gender-Diverse Patients With Breast Cancer.
    Cortina CS, Brazauskas R, Flanagan MR, Dill ED, Joseph KP, Trifonov A, Mukhtar RA, Kim EA, Kantor O, Barmettler G, Rezak KM, Rosenberger LH, Jordan SW, Perez MM, Jimenez RB, Smart AC, Kopkash KA, Hughes TM, Walker JC, Lautner MA, Siegel EL, Brabender DE, Al-Hilli Z, Cassidy MR, Weiss A, McCaffrey RL, Lee MC, Kaoutzanis C, Nguyen KN, Son JD, Williams AD, Madrigrano A, McLaughlin SA, Petroll AE, Stolley M
    JAMA Netw Open. 2026 07 01; 9(7):e2624824.; 
    PubMed
  13. FNA biopsy of breast specimens effectively harvests cells for patient-derived organoids modeling ductal carcinoma in situ.
    Ye J, Goldhammer N, Vohra P, Warhadpande S, de Castro GC, Rodas CKM, Moasser MM, Ramalingam K, Abe SE, Alvarado M, Ewing C, Goodwin KM, Mukhtar RA, Wong JM, Esserman LJ, Balassanian R, Rosenbluth JM
    Cancer Cytopathol. 2025 11; 133(11):e70052.; 
    PubMed
  14. Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial.
    Kaur M, Dimitroff K, Boughey JC, Esserman LJ, Yau C, Tchou J, Quirarte A, Lee MC, Howard-McNatt MM, Switalla K, Kuerer H, Sauder C, Postlewait LM, Arciero C, Rao R, Wallace A, Reyna C, Ahmed K, Gutnik L, Taunk N, Perlmutter J, DeMichele A, Yee D, Hylton NM, Symmans WF, Rugo HS, Shatsky RA, Isaacs C, Rudra S, Pohlmann P, Ewing C, Wong J, Alvarado M, Jaskowiak N, Prionas N, Golshan M, Piltin MA, Olopade OI, Mukhtar RA
    Ann Surg Oncol. 2025 Oct; 32(11):8211-8219.; 
    PubMed
  15. UCSF Research Profile ">Circulating tumor DNA (ctDNA) in patients with stage 2/3 HR+HER2-negative breast cancer (BC) treated with neoadjuvant endocrine therapy (NET) in the I-SPY2 endocrine optimization pilot (EOP) trial.
    Silver Alkhafaji, Mark Jesus M Magbanua, Laura van t Veer, Karthik Giridhar, Matthew P. Goetz, Rita Mukhtar, Christos Vaklavas, Anthony D. Elias, Mei Wei, Gillian L. Hirst, Hope S. Rugo, Laura Ann Huppert, W. Fraser Fraser Symmans, Alexander D. Borowsky, Lamorna Brown Swigart, Natsuko Onishi, Douglas Yee, Nola Hylton, Laura Esserman, Jo Chien
    Journal of Clinical Oncology. 2025 Jun 1; 43(16_suppl):3008-3008.; 
    UCSF Research Profile ">UCSF Research Profile
  16. UCSF Research Profile ">Abstract 2367: Changes in breast hormone signaling and inflammation underlie radiologic features of cancer risk.
    Nadine Goldhammer, Marin Bont, Michael Choi, Shruti Warhadpande, Heather Greenwood, Soumi Gottipati, Tam Binh Bui, Michael Bruck, Shoko Emily Abe, Michael Alvarado, Cheryl Ewing, Karen Goodwin, Rita Mukhtar, Jasmine Wong, Laura van't Veer, Nola Hylton, Laura J. Esserman, Jennifer M. Rosenbluth
    Cancer Research. 2025 Apr 21; 85(8_Supplement_1):2367-2367.; 
    UCSF Research Profile ">UCSF Research Profile
  17. Reply to: "Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium and the National Cancer Database (NCDB)".
    Kaur M, Rothschild HT, Mukhtar RA
    Breast Cancer Res Treat. 2024 Oct; 207(3):669-670.; 
    PubMed
  18. Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
    Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA
    Ann Surg Oncol. 2024 Oct; 31(11):7249-7259.; 
    PubMed
  19. Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment.
    Corso G, Fusco N, Guerini-Rocco E, Leonardi MC, Criscitiello C, Zagami P, Nicolò E, Mazzarol G, La Vecchia C, Pesapane F, Zanzottera C, Tarantino P, Petitto S, Bianchi B, Massari G, Boato A, Sibilio A, Polizzi A, Curigliano G, De Scalzi AM, Lauria F, Bonanni B, Marabelli M, Rotili A, Nicosia L, Albini A, Calvello M, Mukhtar RA, Robson ME, Sacchini V, Rennert G, Galimberti V, Veronesi P, Magnoni F
    Semin Oncol. 2024 Jun-Aug; 51(3-4):106-122.; 
    PubMed
  20. Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer risk.
    Northey JJ, Hayward MK, Yui Y, Stashko C, Kai F, Mouw JK, Thakar D, Lakins JN, Ironside AJ, Samson S, Mukhtar RA, Hwang ES, Weaver VM
    Cell Stem Cell. 2024 01 04; 31(1):106-126.e13.; 
    PubMed
  21. Erratum: 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression - CORRIGENDUM.
    Rothschild HT, Jo Chien A, Jankowitz RC, Magbanua MJ, Mouabbi JA, Shatsky RA, Levine J, Mukhtar RA
    J Clin Transl Sci. 2023; 7(1):e202.; 
    PubMed
  22. ASO Author Reflections: Patient, Tumor, and Treatment Characteristics Predict Early Versus Late Recurrence in Patients with Invasive Lobular Carcinoma of the Breast.
    Rothschild HT, Mukhtar RA
    Ann Surg Oncol. 2023 10; 30(10):6008-6009.; 
    PubMed
  23. UCSF Research Profile ">53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression.
    Harriet T Rothschild, A Jo Chien, Rachel C Jankowitz, Mark JM Magbanua, Jason A Mouabbi, Rebecca A Shatsky, Julia Levine, Rita A Mukhtar
    Journal of Clinical and Translational Science. 2023 Apr 24; 7(s1):14-14.; 
    UCSF Research Profile ">UCSF Research Profile
  24. Expanding Candidacy for Nipple-sparing Mastectomy in Women with Large or Ptotic Breasts: Staged Reconstruction Outcomes.
    Barnes LL, Foster R, Mukhtar RA, Esserman LJ, Ewing C, Alvarado M, Wong J, Piper M
    Plast Reconstr Surg Glob Open. 2023 Jan; 11(1):e4767.; 
    PubMed
  25. The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study.
    Abel MK, Shui AM, Chien AJ, Rugo HS, Melisko M, Baehner F, Mukhtar RA
    Ann Surg Oncol. 2022 Nov; 29(12):7739-7747.; 
    PubMed
  26. UCSF Research Profile ">Abstract P3-02-01: Initial experience of FES-dedicated breast PET imaging of early-stage ER+ invasive lobular carcinoma.
    Ella F Jones, Deep K Hathi, Natalia Konovalova, Julissa Molina-Vega, David C Newitt, Courtney Lawhn-Heath, Kimberly M Ray, Bonnie N Joe, Diane Heditsian, Susie Brain, A. Jo Chien, Laura J Esserman, Nola M Hylton, Rita A Mukhtar
    Cancer Research. 2022 Feb 15; 82(4_Supplement):p3-02-01-p3-02-01.; 
    UCSF Research Profile ">UCSF Research Profile
  27. Trigger point injection for post-mastectomy pain: a simple intervention with high rate of long-term relief.
    Khoury AL, Keane H, Varghese F, Hosseini A, Mukhtar R, Eder SE, Weinstein PR, Esserman LJ
    NPJ Breast Cancer. 2021 Sep 17; 7(1):123.; 
    PubMed
  28. UCSF Research Profile ">Decreased enrollment of patients with advanced lobular breast cancer compared to ductal breast cancer in interventional clinical trials.
    Mary Kathryn Abel, Michelle E. Melisko, Hope S. Rugo, Amy Jo Chien, Italia Diaz, Julia K. Levine, Ann Griffin, Joseph McGuire, Laura Esserman, Hala Borno, Rita A. Mukhtar
    Journal of Clinical Oncology. 2021 May 20; 39(15_suppl):1092-1092.; 
    UCSF Research Profile ">UCSF Research Profile
  29. UCSF Research Profile ">Abstract PD5-01: Magnetic resonance imaging insights from an active surveillance cohort of women with DCIS.
    Heather Greenwood, Rita Freimanis, Case Brabham, Rita Mukhtar, Gillian Hirst, Paul Kim, April Liang, Laura Esserman, Nola Hylton, Amrita Basu
    Cancer Research. 2021 Feb 15; 81(4_Supplement):pd5-01-pd5-01.; 
    UCSF Research Profile ">UCSF Research Profile
  30. Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217.
    Northey JJ, Barrett AS, Acerbi I, Hayward MK, Talamantes S, Dean IS, Mouw JK, Ponik SM, Lakins JN, Huang PJ, Wu J, Shi Q, Samson S, Keely PJ, Mukhtar RA, Liphardt JT, Shepherd JA, Hwang ES, Chen YY, Hansen KC, Littlepage LE, Weaver VM
    J Clin Invest. 2020 11 02; 130(11):5721-5737.; 
    PubMed
  31. Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival.
    Mukhtar RA, Krings G, Chen YY, Mamounas ME, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Rugo H
    Breast Cancer Res Treat. 2020 May; 181(1):23-29.; 
    PubMed
  32. Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study.
    Cao CX, Sharib JM, Blanco AM, Goldberg D, Bracci P, Mukhtar RA, Esserman LJ, Kirkwood KS
    J Am Coll Surg. 2020 01; 230(1):53-63.e1.; 
    PubMed
  33. UCSF Research Profile ">Abstract P1-15-15: Accuracy of MRI after neoadjuvant therapy for invasive lobular carcinoma of the breast.
    KE Fahrner-Scott, JM Wong, M Piper, C Ewing, M Alvarado, LJ Esserman, N Hylton, RA Mukhtar
    Poster Session Abstracts. 2019 Feb 15; p1-15-15-p1-15-15.; 
    UCSF Research Profile ">UCSF Research Profile
  34. Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients.
    Mukhtar RA, Wong J, Piper M, Zhu Z, Fahrner-Scott K, Mamounas M, Sbitany H, Alvarado M, Foster R, Ewing C, Esserman L
    Ann Surg Oncol. 2018 Oct; 25(11):3165-3170.; 
    PubMed
  35. How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer.
    Price ER, Wong J, Mukhtar R, Hylton N, Esserman LJ
    World J Clin Cases. 2015 Jul 16; 3(7):607-13.; 
    PubMed
  36. Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer.
    Mukhtar RA, Moore AP, Tandon VJ, Nseyo O, Twomey P, Adisa CA, Eleweke N, Au A, Baehner FL, Moore DH, McGrath MS, Olopade OI, Gray JW, Campbell MJ, Esserman LJ
    Ann Surg Oncol. 2012 Nov; 19(12):3979-86.; 
    PubMed
  37. UCSF Research Profile ">Abstract P2-09-11: Response of Invasive Lobular Cancers to Neoadjuvant Therapy.
    RA Mukhtar, ES Hwang, C Livasy, LJ. Esserman
    Poster Session Abstracts. 2010 Dec 15; p2-09-11-p2-09-11.; 
    UCSF Research Profile ">UCSF Research Profile
  38. Multidisciplinary Management Considerations in Invasive Lobular Breast Cancer: It Isn't Just Ductal.
    Beck AC, Carroll EF, Mukhtar RA, Cassidy MR, Flanagan MR, Gamble LA, Erdahl LM
    Ann Surg Oncol. 2026 Oct; 33(11):9933-9943.; 
    PubMed
  39. Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status.
    Corso G, Andreon C, La Vecchia C, Bottazzoli EI, Abruzzese G, Favilla K, Citterio O, Spoldi E, Di Silvestre S, De Scalzi AM, Polizzi A, Meduri E, Trapani D, Nicosia L, Pesapane F, Bossi D, Brogi E, Shen S, Mukhtar R, Criscitiello C, Veronesi P, Gandini S, Magnoni F, Curigliano G
    Eur J Cancer. 2026 May 15; 239:116692.; 
    PubMed
  40. UCSF Research Profile ">ASO Visual Abstract: Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial.
    M. Kaur, K. Dimitroff, J. C. Boughey, L. J. Esserman, C. Yau, J. Tchou, A. Quirarte, M. C. Lee, M. M. Howard-McNatt, K. Switalla, H. Kuerer, C. Sauder, L. M. Postlewait, C. Arciero, Roshni Rao, A. Wallace, C. Reyna, K. Ahmed, L. Gutnik, N. Taunk, J. Perlmutter, A. DeMichele, D. Yee, N. M. Hylton, F. Symmans, H. S. Rugo, R. A. Shatsky, C. Isaacs, S. Rudra, P. Pohlmann, C. Ewing, J. Wong, M. Alvarado, N. Jaskowiak, N. Prionas, M. Golshan, M. A. Piltin, O. I. Olopade, R. A. Mukhtar
    Annals of Surgical Oncology. 2025 Aug 21; 1-2.; 
    UCSF Research Profile ">UCSF Research Profile
  41. Accuracy of Breast MRI for Surgical Planning After Neoadjuvant Therapy for Patients with Invasive Lobular Carcinoma.
    Vertido A, McKenzie T, Othieno A, Quirarte A, Kaur M, Abel MK, Chung M, Lee AY, Mukhtar RA
    Ann Surg Oncol. 2025 Nov; 32(12):8710-8719.; 
    PubMed
  42. UCSF Research Profile ">Reframing hormone-positive DCIS management: Effects of adjuvant therapies and surgical extent on any invasive recurrence.
    Thomas O'Keefe, Christina Yau, Sophie Lin, Nicolas Prionas, Gillian L. Hirst, Rita Mukhtar, Anne M. Wallace, Michael Alvarado, Laura Esserman
    Journal of Clinical Oncology. 2025 Jun 1; 43(16_suppl):572-572.; 
    UCSF Research Profile ">UCSF Research Profile
  43. A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer.
    Mukhtar RA, Gottipati S, Yau C, López-Tarruella S, Earl H, Hayward L, Hiller L, Osdoit M, van der Noordaa M, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, Boughey JC, Goetz MP, Hoskin T, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Provenzano E, Sammut SJ, Thomas JS, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, J van 't Veer L, Cameron D, Esserman LJ, Fraser Symmans W
    NPJ Breast Cancer. 2025 Feb 13; 11(1):14.; 
    PubMed
  44. Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer.
    Tchou J, Gottipati S, Goldbach M, Baxter M, Venters S, Balassanian R, Vohra P, Gonzalves D, Ahmad Z, Nayak A, Boughey JC, Mukhtar RA, Chen YY
    Ann Surg Oncol. 2024 Nov; 31(12):8093-8101.; 
    PubMed
  45. UCSF Research Profile ">Elucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer.
    Erin Frances Cobain, Lajos Pusztai, Cathy Lynne Graham, Pat W. Whitworth, Peter D. Beitsch, Cynthia R. C. Osborne, Rakhshanda Layeequr Rahman, Nathalie MCDOWELL Johnson, Adam Brufsky, Reshma L. Mahtani, VK Gadi, Kent Hoskins, Hannah M. Linden, Rita A. Mukhtar, Laura Esserman, Josien Haan, Katie Quinn, Andrea Menicucci, M. William Audeh, Joyce O'Shaughnessy
    Journal of Clinical Oncology. 2024 Jun 1; 42(16_suppl):506-506.; 
    UCSF Research Profile ">UCSF Research Profile
  46. UCSF Research Profile ">Abstract PO4-02-03: Distribution of MammaPrint, BluePrint, and Response Predictive Subtypes based on ImPrint and Reprint in ER+/HER2- Invasive Lobular Carcinoma – A FLEX sub study.
    Rita Mukhtar, Christina Yau, Denise Wolf, Adam Brufsky, Hannah Linden, Natasha Hunter, Reshma Mahtani, Abirami Sivapiragasam, Trevor Feinstein, Fengting Yan, Ian Grady, Priscilla McAuliffe, Michaela Tsai, Joyce O'Shaughnessy, Blanche Mavromatis, Sasha Davis, Josien Haan, William Audeh, Lavanya Samraj
    Cancer Research. 2024 May 2; 84(9_Supplement):po4-02-03-po4-02-03.; 
    UCSF Research Profile ">UCSF Research Profile
  47. ASO Visual Abstract: Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.
    Ramalingam K, Clelland E, Rothschild H, Mujir F, Record H, Kaur M, Mukhtar RA
    Ann Surg Oncol. 2023 11; 30(12):7152.; 
    PubMed
  48. Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.
    Ramalingam K, Clelland E, Rothschild H, Mujir F, Record H, Kaur M, Mukhtar RA
    Ann Surg Oncol. 2023 Nov; 30(12):7099-7106.; 
    PubMed
  49. Metabolic Positron Emission Tomography in Breast Cancer.
    Cecil K, Huppert L, Mukhtar R, Dibble EH, O'Brien SR, Ulaner GA, Lawhn-Heath C
    PET Clin. 2023 Oct; 18(4):473-485.; 
    PubMed
  50. UCSF Research Profile ">Abstract P2-03-16: Quantifying estrogen and progesterone receptor status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.
    Elle Clelland, Harriet T. Rothschild, Anne Patterson, Julissa Molina-Vega, Mandeep Kaur, Mary Kathryn Abel, W. Fraser Symmans, Jo Chien, Christopher J. Schwartz, Rita Mukhtar
    Cancer Research. 2023 Mar 1; 83(5_Supplement):p2-03-16-p2-03-16.; 
    UCSF Research Profile ">UCSF Research Profile
  51. ASO Visual Abstract: The 21-Gene Recurrence Score in Clinically High Risk Lobular and Ductal Breast Cancer-A National Cancer Database Study.
    Abel MK, Shui AM, Chien AJ, Rugo HS, Melisko M, Baehner F, Mukhtar RA
    PubMed
  52. UCSF Research Profile ">Pathologic complete response (pCR) rates for HR+/HER2- breast cancer by molecular subtype in the I-SPY2 Trial.
    Laura Ann Huppert, Hope S. Rugo, Lajos Pusztai, Rita A. Mukhtar, Amy Jo Chien, Christina Yau, Denise M. Wolf, Donald A. Berry, Laura van 't Veer, Douglas Yee, Angela DeMichele, Laura Esserman
    Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):504-504.; 
    UCSF Research Profile ">UCSF Research Profile
  53. The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study.
    Abel MK, Shui AM, Melisko M, Chien AJ, Yoshida EJ, Lancaster EM, Van 't Veer L, Esserman LJ, Mukhtar RA
    NPJ Breast Cancer. 2021 Dec 21; 7(1):156.; 
    PubMed
  54. Preventing Recurrence in Clean and Contaminated Hernias Using Biologic Versus Synthetic Mesh in Ventral Hernia Repair: The PRICE Randomized Clinical Trial.
    Harris HW, Primus F, Young C, Carter JT, Lin M, Mukhtar RA, Yeh B, Allen IE, Freise C, Kim E, Sbitany H, Young DM, Hansen S
    Ann Surg. 2021 04 01; 273(4):648-655.; 
    PubMed
  55. UCSF Research Profile ">Abstract PS17-05: Relationship between body mass index and tumor subtype by menopausal status: An analysis in women with lobular carcinoma of the breast.
    Harriet Rothschild, Laura Esserman, Christopher Benz, Rita Mukhtar
    Cancer Research. 2021 Feb 15; 81(4_Supplement):ps17-05-ps17-05.; 
    UCSF Research Profile ">UCSF Research Profile
  56. Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast.
    Abel MK, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Park C, Mukhtar RA
    Breast Cancer Res Treat. 2020 Oct; 183(3):661-667.; 
    PubMed
  57. UCSF Research Profile ">Abstract P4-13-01: Trends in primary management of invasive lobular carcinoma: An analysis of the National Cancer Database (NCDB).
    Rita A Mukhtar, Tanya L. Hoskin, Elizabeth B. Habermann, Judy C. Boughey
    Cancer Research. 2020 Feb 15; 80(4_Supplement):p4-13-01-p4-13-01.; 
    UCSF Research Profile ">UCSF Research Profile
  58. Feasibility of Magnetic Seeds for Preoperative Localization of Axillary Lymph Nodes in Breast Cancer Treatment.
    Greenwood HI, Wong JM, Mukhtar RA, Alvarado MD, Price ER
    AJR Am J Roentgenol. 2019 10; 213(4):953-957.; 
    PubMed
  59. UCSF Research Profile ">Abstract PD7-06: Molecular subtypes of invasive lobular breast cancer in the I-SPY2 TRIAL.
    Z Zhu, C Yau, AJ Chien, T Haddad, LJ Esserman, L van't Veer, RA Mukhtar
    Cancer Research. 2019 Feb 15; 79(4_Supplement):pd7-06-pd7-06.; 
    UCSF Research Profile ">UCSF Research Profile
  60. UCSF Research Profile ">Abstract P5-12-04: The impact of bariatric surgery on mammographic breast density.
    A Hosseini, AL Khoury, J Carter, JM Wong, MD Alvarado, C Ewing, LJ Esserman, RA Mukhtar
    Poster Session Abstracts. 2018 Feb 15; p5-12-04-p5-12-04.; 
    UCSF Research Profile ">UCSF Research Profile
  61. UCSF Research Profile ">Abstract 165: Suppressed immunity and macrophages characterize high risk high grade DCIS.
    Michael J. Campbell, Rita Mukhtar, Ekene Obi-Okoye, Booyeon Han, Vick Tandon, Sarah Zheng, Zelos Zhu, Max Endicott, Max Wicha, Linda Lindstrom, Alfred Au, Frederick Baehner, Joe Gray, Laura Esserman
    Tumor Biology. 2014 Oct 1; 165-165.; 
    UCSF Research Profile ">UCSF Research Profile
  62. UCSF Research Profile ">PD02-05: MRI Phenotype and Tumor Subtype Affect Breast Conservation Eligibility and MRI Accuracy in the I-SPY 1 Trial.
    RA Mukhtar, N Hylton, M Rosen
    Poster Discussion Abstracts. 2011 Dec 15; pd02-05-pd02-05.; 
    UCSF Research Profile ">UCSF Research Profile
  63. Bacteriologic features of surgical site infections following breast surgery.
    Mukhtar RA, Throckmorton AD, Alvarado MD, Ewing CA, Esserman LJ, Chiu C, Hwang ES
    Am J Surg. 2009 Oct; 198(4):529-31.; 
    PubMed
  64. ASO Visual Abstract: Multidisciplinary Management Considerations in Invasive Lobular Breast Cancer: It Isn't Just Ductal.
    Beck AC, Carroll EF, Mukhtar RA, Cassidy MR, Flanagan MR, Gamble LA, Erdahl LM
    Ann Surg Oncol. 2026 Oct; 33(11):9944-9945.; 
    PubMed
  65. ASO Author Reflections: Young Women with Breast Cancer may Safely Opt for Breast Conservation After Neoadjuvant Therapy.
    Tseng J, Boughey JC, Mukhtar RA
    Ann Surg Oncol. 2026 Oct; 33(11):9657-9658.; 
    PubMed
  66. Impact of concurrent lobular carcinoma in situ on recurrence outcomes in patients with classic and pleomorphic invasive lobular carcinoma of the breast.
    Kaur M, Quirarte A, Vertido A, Torosian T, Li TM, Mouabbi JA, Mukhtar RA
    Breast Cancer Res Treat. 2025 Nov 27; 215(1):20.; 
    PubMed
  67. UCSF Research Profile ">ASO Visual Abstract: Accuracy of Breast MRI for Surgical Planning After Neoadjuvant Therapy for Patients with Invasive Lobular Carcinoma.
    Anna Vertido, Tesia McKenzie, Alisha Othieno, Astrid Quirarte, Mandeep Kaur, Mary Kathryn Abel, Maggie Chung, Amie Y. Lee, Rita A. Mukhtar
    Annals of Surgical Oncology. 2025 Jul 30; 1-2.; 
    UCSF Research Profile ">UCSF Research Profile
  68. ASO Author Reflections: Reassessing Positive Margins in Breast-Conserving Surgery: The Role of Histology and Oncoplastic Surgery.
    Switalla KM, Mukhtar RA
    Ann Surg Oncol. 2025 Sep; 32(9):6691-6692.; 
    PubMed
  69. A Multi-Institutional Analysis of Contralateral Axillary Metastases: Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer.
    Flanagan MR, van den Bruele AMB, Downs-Canner SM, Thomas SM, Gallagher KK, Jakub JW, Tevis SEA, Verdial FC, Zhang JQ, Elmore LC, Mukhtar RA, Brennan M, Lillie M, Gibson TC, Verosky A, Plichta JK, Rosenberger LH
    Ann Surg Oncol. 2025 Aug; 32(8):5551-5562.; 
    PubMed
  70. Balancing risks of surgical complications and positive margins for patients with invasive lobular carcinoma of the breast and elevated BMI: An institutional cohort study.
    Falade I, Switalla K, Quirarte A, Baxter M, Soroudi D, Rothschild H, Abe SE, Goodwin K, Piper M, Alvarado M, Julian BQ, Ewing C, Wong J, Rose J, Esserman L, Foster R, Mukhtar RA
    Am J Surg. 2025 Mar; 241:116073.; 
    PubMed
  71. ASO Author Reflections: Detecting Local Recurrence After Primary Treatment for Invasive Lobular Carcinoma of the Breast.
    Clelland EN, Mukhtar RA
    Ann Surg Oncol. 2024 Oct; 31(11):7323-7324.; 
    PubMed
  72. UCSF Research Profile ">I-SPY2 Endocrine Optimization Pilot (EOP): Neoadjuvant amcenestrant +/- abemaciclib +/- letrozole in molecularly selected patients (pts) with HR+ HER2- stage 2/3 breast cancer (BC).
    Amy Jo Chien, Rita A. Mukhtar, Karthik Giridhar, Olufunmilayo I. Olopade, Kevin Kalinsky, Christos Vaklavas, Anthony D. Elias, Mei Wei, Matthew P. Goetz, Laura van 't Veer, Silver Alkhafaji, Hope S. Rugo, Nan Chen, W. Fraser Fraser Symmans, Alexander D. Borowsky, Lamorna Brown Swigart, Natsuko Onishi, Douglas Yee, Nola Hylton, Laura Esserman
    Journal of Clinical Oncology. 2024 May 29; 42(16_suppl):601-601.; 
    UCSF Research Profile ">UCSF Research Profile
  73. UCSF Research Profile ">Abstract A059: Heterogeneous cell populations in organoid models derived from breast preinvasive and invasive carcinomas after endocrine therapy.
    Nadine Goldhammer, Shruti Warhadpande, Liana Beld, Cristian K. Maldonado Rodas, Allison Lam, Tam Binh Bui, Shoko Emily Abe, Michael Alvarado, Cheryl Ewing, Karen Goodwin, Rita Mukhtar, Jasmine Wong, Lamorna Brown Swigart, Gillian Hirst, Christopher Schwartz, Laura van't Veer, Laura Esserman, Jo Chien, Jennifer M. Rosenbluth
    Cancer Research. 2024 Feb 1; 84(3_Supplement_1):a059-a059.; 
    UCSF Research Profile ">UCSF Research Profile
  74. The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB).
    Rothschild HT, Clelland EN, Abel MK, Chien AJ, Shui AM, Esserman L, Khan SA, Mukhtar RA
    Breast Cancer Res Treat. 2024 Jan; 203(2):245-256.; 
    PubMed
  75. The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database.
    Rothschild HT, Clelland EN, Abel MK, Chien AJ, Shui AM, Esserman L, Khan SA, Mukhtar RA
    Res Sq. 2023 Jul 19.; 
    PubMed
  76. Time to Surgery in Breast Cancer-Is Faster Always Better?
    Mukhtar RA, Esserman LJ
    JAMA Surg. 2023 05 01; 158(5):492-493.; 
    PubMed
  77. UCSF Research Profile ">Abstract P6-08-09: Self-identified race and Area Deprivation Index in patients with invasive lobular carcinoma of the breast: associations with tumor characteristics and event free survival.
    Mandeep Kaur, Anne Patterson, Julissa Molina-Vega, Harriet T. Rothschild, Elle Clelland, Mary Kathryn Abel, Laura J. Esserman, Olufunmilayo I. Olopade, Rita Mukhtar
    Cancer Research. 2023 Mar 1; 83(5_Supplement):p6-08-09-p6-08-09.; 
    UCSF Research Profile ">UCSF Research Profile
  78. Molecular Imaging for Estrogen Receptor-Positive Breast Cancer: Clinical Applications of Whole Body and Dedicated Breast Positron Emission Tomography.
    Goodman K, Abel MK, Lawhn-Heath C, Molina-Vega J, Jones EF, Mukhtar RA
    Surg Oncol Clin N Am. 2022 10; 31(4):569-579.; 
    PubMed
  79. UCSF Research Profile ">Abstract OT1-10-02: I-SPY2 endocrine optimization protocol (EOP): A pilot neoadjuvant endocrine therapy study with amcenestrant as monotherapy or in combination with abemacicilib or letrozole in molecularly selected HR+/HER2- clinical stage 2/3 breast can
    A. Jo Chien, Kevin M Kalinsky, Julissa Molina-Vega, Rita Mukhtar, Karthik Giridhar, Olufunmilayo I Olopade, Amrita Basu, Smita M Asare, Paul Henderson, Gillian Hirst, Ruixiao Lu, Ella Jones, Nola Hylton, Lamorna Brown-Swigart, Laura J van 't Veer, Douglas Yee, Ingrid Mayer, Laura J Esserman
    cer. Cancer Research. 2022 Feb 15; 82(4_Supplement):ot1-10-02-ot1-10-02.; 
    UCSF Research Profile ">UCSF Research Profile
  80. Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?
    Abel MK, Melisko ME, Rugo HS, Chien AJ, Diaz I, Levine JK, Griffin A, McGuire J, Esserman LJ, Borno HT, Mukhtar RA
    NPJ Breast Cancer. 2021 Oct 25; 7(1):139.; 
    PubMed
  81. Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB).
    Mukhtar RA, Hoskin TL, Habermann EB, Day CN, Boughey JC
    Ann Surg Oncol. 2021 Oct; 28(11):5867-5877.; 
    PubMed
  82. A world-wide survey on kidney transplantation practices in breast cancer survivors: The need for new management guidelines.
    Hansen KS, Ghersin H, Piper M, Tavakol M, Lee B, Esserman LJ, Roberts JP, Freise C, Ascher NL, Mukhtar RA
    Am J Transplant. 2021 09; 21(9):3014-3020.; 
    PubMed
  83. UCSF Research Profile ">4314 The Impact of Axillary Surgery on Recurrence-Free Survival in Invasive Lobular Carcinoma (ILC) of the Breast.
    Mary Kathryn Reed Abel, Jasmine Wong, Michael Alvarado, Cheryl Ewing, Laura J. Esserman, Catherine Park, Rita A. Mukhtar
    Journal of Clinical and Translational Science. 2020 Jun 1; 4(s1):38-38.; 
    UCSF Research Profile ">UCSF Research Profile
  84. UCSF Research Profile ">Abstract PD9-08: Accuracy of ultrasound in evaluating response to neoadjuvant therapy in invasive lobular carcinoma of the breast.
    Kelly Fahrner-Scott, Jasmine M Wong, Merisa Piper, Cheryl Ewing, Michael Alvarado, Laura J Esserman, Nola Hylton, Rita A Mukhtar
    Cancer Research. 2020 Feb 15; 80(4_Supplement):pd9-08-pd9-08.; 
    UCSF Research Profile ">UCSF Research Profile
  85. UCSF Research Profile ">Abstract 118: The Impact of Post-Operative Prophylactic Antibiotics in Immediate 2-Stage Prepectoral Breast Reconstruction.
    Michael Holland, Rachel Lentz, Clara Gomez-Sanchez, Jami Rothman, Jasmine Wong, Rita Mukhtar, Hani Sbitany
    Plastic & Reconstructive Surgery Global Open. 2019 Apr 1; 7(4 Suppl):82-83.; 
    UCSF Research Profile ">UCSF Research Profile
  86. ASO Author Reflections: Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients.
    Mukhtar RA
    Ann Surg Oncol. 2018 12; 25(Suppl 3):622-623.; 
    PubMed
  87. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
    Campbell MJ, Baehner F, O'Meara T, Ojukwu E, Han B, Mukhtar R, Tandon V, Endicott M, Zhu Z, Wong J, Krings G, Au A, Gray JW, Esserman L
    Breast Cancer Res Treat. 2017 01; 161(1):17-28.; 
    PubMed
  88. Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
    Lips EH, Mukhtar RA, Yau C, de Ronde JJ, Livasy C, Carey LA, Loo CE, Vrancken-Peeters MJ, Sonke GS, Berry DA, Van't Veer LJ, Esserman LJ, Wesseling J, Rodenhuis S, Shelley Hwang E, I-SPY TRIAL Investigators
    Breast Cancer Res Treat. 2012 Nov; 136(1):35-43.; 
    PubMed
  89. UCSF Research Profile ">Benign Thoracic Disease in the Elderly.
    Rita A. Mukhtar, Pierre R. Theodore
    Cardiothoracic Surgery in the Elderly. 2011 Jan 1; 517-526.; 
    UCSF Research Profile ">UCSF Research Profile
  90. Image of the month--quiz case. Traumatic intramuscular cyst of the duodenum.
    Spitzer AL, Mukhtar RA, Harris HW
    Arch Surg. 2005 Oct; 140(10):1005-6.; 
    PubMed
  91. Correction: ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.
    Tseng J, Dimitroff K, Sauder CAM, Chien AJ, Ahmed KA, Allen LF, Arciero CA, Burke EE, Chandler JM, Jordan JE, Golshan M, Gutnik LA, Jaskowiak NT, Hewitt KC, Howard-McNatt M, Ito F, Kang IM, Kesmodel SB, Kuerrer HM, Lee MC, Moran MS, Postlewait LM, Prionas ND, Rao R, Reyna CR, Schwer A, Taunk NK, Tchou J, Wallace AM, Li TJ, Perlmutter J, DeMichele AM, Yee D, Hylton NM, Veer LJV, Rugo HS, Symmans WF, Shatsky RA, Isaacs CJD, Yau C, Esserman LJ, Boughey JC, Mukhtar RA
    Ann Surg Oncol. 2026 Sep 05.; 
    PubMed
  92. A prospective single-arm pilot study evaluating [F-18]fluoroestradiol dedicated breast PET in invasive lobular carcinoma after neoadjuvant endocrine therapy.
    Switalla KM, Onishi N, Jones EF, Lawhn-Heath C, Ray KM, Hathi DK, Carmona-Bozo JC, Metanat P, Lopes AJ, Falade IO, Quirarte A, Gottipati S, Guo R, Molina-Vega J, Pullakhandam K, Bareng TJ, Watkins M, Chien AJ, Joe BN, Esserman LJ, Hylton N, Mukhtar RA
    Breast Cancer Res. 2026 Apr 11; 28(1).; 
    PubMed
  93. UCSF Research Profile ">ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
    Rita A. Mukhtar, Katrina Dimitroff, Christina Yau, A. Jo Chien, Eileen P. Connolly, Marissa Howard-McNatt, Roshni Rao, Velle Ladores, Mehra Golshan, Candice A. Sauder, Kamran Ahmed, Rachael Lancaster, Jana Fox, Lily Gutnik, M. Catherine Lee, Julia Tchou, Nicolas Prionas, Cletus A. Arciero, Chantal Reyna, Henry Kuerer, Kayla Switalla, Neil Taunk, Todd M. Tuttle, Meena S. Moran, Lauren M. Postlewait, Jane Perlmutter, Angela DeMichele, Douglas Yee, Nola Hylton, W. Fraser Symmans, Hope S. Rugo, Rebecca Shatsky, Claudine Isaacs, Laura J. Esserman, Laura van ‘t Veer, Judy C. Boughey
    Annals of Surgical Oncology. 2025 Aug 23; 1-2.; 
    UCSF Research Profile ">UCSF Research Profile
  94. Clinical challenges and proposed solutions for patients with invasive lobular breast cancer.
    Van Baelen K, Sawyer E, Van Cauwenberge J, Aftimos P, Covington MF, Maetens M, Zels G, Brisken C, Djerroudi L, Dresen R, Fitzpatrick A, Flaherty RL, Floris G, Freeney S, Hanker AB, Honey D, Isacke CM, Jankowitz RC, Jeselsohn R, Koorman T, Kuhl C, Linn S, Lord CJ, Malhaire C, Mouabbi J, Mukhtar R, Nader-Marta G, Natrajan R, Neven P, Oesterreich S, Sandoval JL, Schnitt SJ, Senkus E, Turner C, Vandecaveye V, Wildiers H, Vincent-Salomon A, Derksen PWB, Desmedt C
    Ann Oncol. 2025 11; 36(11):1285-1298.; 
    PubMed
  95. UCSF Research Profile ">I-SPY2 endocrine optimization pilot (EOP): Neoadjuvant lasofoxifene (Laso) in molecularly selected patients with hormone receptor positive (HR+)/HER2 negative (HER2-) stage 2/3 breast cancer (BC).
    Mei Wei, Anthony D. Elias, Karthik Giridhar, Matthew P. Goetz, Rita Mukhtar, Christos Vaklavas, Laura van t Veer, Silver Alkhafaji, Gillian L. Hirst, Hope S. Rugo, Nan Chen, W. Fraser Fraser Symmans, Alexander D. Borowsky, Lamorna Brown Swigart, Natsuko Onishi, Douglas Yee, Nola Hylton, Laura Esserman, Jo Chien
    Journal of Clinical Oncology. 2025 Jun 1; 43(16_suppl):612-612.; 
    UCSF Research Profile ">UCSF Research Profile
  96. UCSF Research Profile ">410 Fine Needle Aspiration Biopsy of Breast Specimens Effectively Harvests Cells for Patient-Derived Organoids Modeling Breast Ductal Carcinoma In Situ.
    Julia Ye, Nadine Goldhammer, Poonam Vohra, Chaelee Park, Cristian Maldonado Rodas, Mark Moasser, Shoko Abe, Michael Alvarado, Cheryl Ewing, Karen Goodwin, Rita Mukhtar, Jasmine Wong, Laura Esserman, Ron Balassanian, Jennifer Rosenbluth
    Laboratory Investigation. 2025 Mar 1; 105(3):102637.; 
    UCSF Research Profile ">UCSF Research Profile
  97. Variation in surgical treatment by body mass index in patients with invasive lobular carcinoma of the breast.
    Falade IO, Switalla KM, Baxter ME, Quirarte A, Record H, Rothschild HT, Clelland EN, Mukhtar RA
    Breast Cancer Res Treat. 2024 Dec; 208(3):569-575.; 
    PubMed
  98. Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.
    Piltin MA, Norwood P, Ladores V, Mukhtar RA, Sauder CA, Golshan M, Tchou J, Rao R, Lee MC, Son J, Reyna C, Hewitt K, Kuerer H, Ahrendt G, Greenwalt I, Tseng J, Postlewait L, Howard-McNatt M, Jaskowiak N, Esserman LJ, Boughey JC, , ISPY2 Locoregional Working Group
    Ann Surg Oncol. 2024 Oct; 31(11):7420-7428.; 
    PubMed
  99. ASO Author Reflections: The Oncologic Safety of Immediate Oncoplastic Approaches in Invasive Lobular Carcinoma.
    Falade I, Mukhtar RA
    Ann Surg Oncol. 2024 Oct; 31(11):7418-7419.; 
    PubMed
  100. ASO Visual Abstract: Nipple-Sparing Mastectomies in Patients over the Age of 60 Years: Factors Associated with Surgical Outcomes.
    Parmeshwar N, Dugan CL, Barnes LL, Cheng JK, Patterson AK, Miller A, Mukhtar R, Piper M
    Ann Surg Oncol. 2024 Jan; 31(1):398-399.; 
    PubMed
  101. Nipple-Sparing Mastectomies in Patients over the Age of 60 Years: Factors Associated with Surgical Outcomes.
    Parmeshwar N, Dugan CL, Barnes LL, Cheng JK, Patterson AK, Miller A, Mukhtar R, Piper M
    Ann Surg Oncol. 2023 Dec; 30(13):8428-8435.; 
    PubMed
  102. Editorial: Contrast mammography-a promising tool for the pre-operative evaluation of lobular breast cancer.
    Jochelson MS, Mukhtar RA
    Eur J Radiol. 2023 09; 166:110982.; 
    PubMed
  103. HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.
    Rothschild HT, Clelland E, Patterson A, Molina-Vega J, Kaur M, Symmans WF, Schwartz CJ, Chien AJ, Mukhtar RA
    Breast Cancer Res Treat. 2023 Jun; 199(2):349-354.; 
    PubMed
  104. Identifying Good Candidates for Active Surveillance of Ductal Carcinoma In Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort.
    Glencer AC, Miller PN, Greenwood H, Maldonado Rodas CK, Freimanis R, Basu A, Mukhtar RA, Brabham C, Kim P, Hwang ES, Rosenbluth JM, Hirst GL, Campbell MJ, Borowsky AD, Esserman LJ
    Cancer Res Commun. 2022 12; 2(12):1579-1589.; 
    PubMed
  105. ASO Author Reflections: Discordant Clinical and Molecular Risk in Invasive Lobular Carcinoma of the Breast: The 21-Gene Recurrence Score in the National Cancer Database by Histologic Subtype.
    Abel MK, Mukhtar RA
    Ann Surg Oncol. 2022 11; 29(12):7748-7749.; 
    PubMed
  106. UCSF Research Profile ">Abstract P3-02-02: FES-dedicated breast PET uptake in early-stage ER+ breast cancers.
    Ella F. Jones, Deep K. Hathi, Julissa Molina-Vega, David C. Newitt, Courtney Lawhn-Heath, Kimberly M. Ray, Bonnie N. Joe, Diane Heditsian, Susie Brain, Rita A. Mukhtar, A. Jo Chien, Hope S. Rugo, Laura J. Esserman, Nola M. Hylton
    Cancer Research. 2022 Feb 15; 82(4_Supplement):p3-02-02-p3-02-02.; 
    UCSF Research Profile ">UCSF Research Profile
  107. Correction to: Applications of 3D printing in breast cancer management.
    Galstyan A, Bunker MJ, Lobo F, Sims R, Inziello J, Stubbs J, Mukhtar R, Kelil T
    3D Print Med. 2021 Jul 07; 7(1):19.; 
    PubMed
  108. Early onset, multiple, bilateral fibroadenomas of the breast: a case report.
    Im CJ, Miller A, Balassanian R, Mukhtar RA
    BMC Womens Health. 2021 04 21; 21(1):170.; 
    PubMed
  109. UCSF Research Profile ">Abstract PD6-08: DCE-MRI derived imaging features for characterizing invasive lobular breast cancer and predicting recurrence-free survival after neoadjuvant therapy.
    Geraldine Tran, Ella Jones, Wen Li, Kelly Fahrner-Scott, David Newitt, Bonnie Joe, Laura Esserman, Nola Hylton, Rita Mukhtar
    Cancer Research. 2021 Feb 15; 81(4_Supplement):pd6-08-pd6-08.; 
    UCSF Research Profile ">UCSF Research Profile
  110. Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience.
    Son JD, Piper M, Hewitt K, Alvarado M, Esserman LJ, Ewing C, Wong JM, Mukhtar RA
    Ann Surg Oncol. 2021 May; 28(5):2555-2560.; 
    PubMed
  111. UCSF Research Profile ">Abstract OT3-09-01: Use of Oncotype DX DCIS for disease management in a prospective DCIS registry.
    Jane M Wei, Paul Kim, Cheryl Ewing, Jasmine Wong, Laura J Esserman, Michael D Alvarado, Abimbola O Olusanya, Skye Stewart, Ashley Tydon, Parima Daroui, Jeffrey V Kuo, Hannah L Park, Karen T Lane, Eliza Jeong, Kelsey Brown, Ava Hosseini, Barbara A Parker, Sarah L Blair, Athena Breast Health Network Investigators, Frederick Baehner, Olivier Harismendy, Antonia Petruse, Carlie K Thompson, Helena R Chang, Alexander D Borowsky, Christina Yau, Gillian L Hirst, Richard J Bold, Rita A Mukhtar
    Cancer Research. 2020 Feb 15; 80(4_Supplement):ot3-09-01-ot3-09-01.; 
    UCSF Research Profile ">UCSF Research Profile
  112. Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast.
    Piper ML, Wong J, Fahrner-Scott K, Ewing C, Alvarado M, Esserman LJ, Mukhtar RA
    NPJ Breast Cancer. 2019; 5:29.; 
    PubMed
  113. UCSF Research Profile ">Abstract P4-11-01: A simple intervention for long-term relief of chronic post mastectomy pain.
    HJ Keane, AL Khoury, A Hosseini, FP Varghese, R Mukhtar, SE Eder, J Wong, LJ Esserman
    Poster Session Abstracts. 2019 Feb 15; p4-11-01-p4-11-01.; 
    UCSF Research Profile ">UCSF Research Profile
  114. UCSF Research Profile ">452 (PB-085) The impact of mitotic score versus pleomorphic subtype on disease free survival in invasive lobular carcinoma of the breast.
    M. Mamounas, J. Wong, K. Fahrner-Scott, Y.Y. Chen, G. Krings, C. Ewing, L. Esserman, M. Alvarado, H. Rugo, R. Mukhtar
    European Journal of Cancer. 2018 Apr 1; 92:s132.; 
    UCSF Research Profile ">UCSF Research Profile
  115. Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer Care.
    Mukhtar RA, Wong JM, Esserman LJ
    J Natl Compr Canc Netw. 2015 Jun; 13(6):737-43.; 
    PubMed
  116. UCSF Research Profile ">P1-06-10: Lobular Breast Cancer and NAC: Combined Results from the NKI and I-SPY 1 Trial.
    RA Mukhtar, E Lips, J Wesseling, C Livasy, C Yau, D Berry, L van't Veer, LA Carey, LJ Esserman, S Rodenhuis, ES Hwang
    Poster Session Abstracts. 2011 Dec 15; p1-06-10-p1-06-10.; 
    UCSF Research Profile ">UCSF Research Profile
  117. UCSF Research Profile ">Evaluation of levels of proliferating macrophages in patients at a county hospital and those with early recurrences.
    R. Mukhtar, A. Moore, O. Nseyo, A. Au, F. L. Baehner, D. H. Moore, M. Campbell, L. Esserman
    Journal of Clinical Oncology. 2010 May 20; 28(15_suppl):1110-1110.; 
    UCSF Research Profile ">UCSF Research Profile
  118. Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.
    Tseng J, Dimitroff K, Sauder CAM, Chien AJ, Ahmed KA, Allen LF, Arciero CA, Burke EE, Chandler JM, Jordan JE, Golshan M, Gutnik LA, Jaskowiak NT, Hewitt KC, Howard-McNatt M, Ito F, Kang IM, Kesmodel SB, Kuerer HM, Lee MC, Moran MS, Postlewait LM, Prionas ND, Rao R, Reyna CR, Schwer A, Taunk NK, Tchou J, Wallace AM, Li TJ, Perlmutter J, DeMichele AM, Yee D, Hylton NM, Veer LJV, Rugo HS, Symmans WF, Shatsky RA, Isaacs CJD, Yau C, Esserman LJ, Boughey JC, Mukhtar RA
    Ann Surg Oncol. 2026 Oct; 33(11):9642-9655.; 
    PubMed
  119. Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissue.
    Goldhammer N, Bont M, Warhadpande S, Choi M, Cedano J, Greenwood H, Ye J, Schwartz CJ, Alvarado M, Ewing C, Goodwin K, Mukhtar RA, Wong J, Abe SE, Chandler J, Jackson J, Olopade OI, Campbell MJ, Lam A, Park C, Vertido A, van 't Veer LJ, Hylton N, Esserman LJ, Rosenbluth JM
    bioRxiv. 2026 Mar 04.; 
    PubMed
  120. Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group.
    Corso G, Shen S, Criscitiello C, Mukhtar R, Gamble L, Rocco EG, Pesapane F, Nicosia L, Jhaveri K, Salimbeni BT, Massari G, Meduri E, De Scalzi AM, Concardi A, Magnoni F, Mamtani A, Pareja F, Leonardi MC, Sacchini V, Bogani G, Vecchia C, Presti D, Colleoni MA, Veronesi P, Robson ME
    Cancer Treat Rev. 2025 Nov; 140:103001.; 
    PubMed
  121. Socioeconomic status impacts tumor biology, treatment, and outcomes in over 200,000 patients with invasive lobular carcinoma of the breast: an analysis of the National Cancer Database.
    Kaur M, Quirarte A, Shui AM, Vertido A, Clelland E, Rothschild H, Esserman LJ, Ewing C, Mukhtar RA
    Breast Cancer Res Treat. 2025 Aug; 213(1):161-169.; 
    PubMed
  122. UCSF Research Profile ">Serum estradiol (sE2) levels in premenopausal (PreM) women receiving neoadjuvant ovarian function suppression (OFS) with the oral SERD amcenestrant, alone, or in combination with letrozole or abemaciclib in the I-SPY2 Endocrine Optimization Pilot (EOP).
    Jo Chien, Peter Norwood, Rita Mukhtar, Karthik Giridhar, Matthew P. Goetz, Christos Vaklavas, Anthony D. Elias, Mei Wei, Hope S. Rugo, Nan Chen, Alexander D. Borowsky, Lamorna Brown Swigart, Rebecca Arielle Shatsky, Laura Ann Huppert, Michelle E. Melisko, Laura Esserman
    Journal of Clinical Oncology. 2025 Jun 1; 43(16_suppl):604-604.; 
    UCSF Research Profile ">UCSF Research Profile
  123. Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial.
    Boughey JC, Yu H, Switalla K, Velle L, Lopes A, Wallace AM, Lancaster RB, Reyna CR, Tuttle TM, Jaskowiak N, Tchou J, Rao R, Lee MC, Naik AM, Golshan M, Arciero CA, Sauder CAM, Matsen CB, Yau C, Esserman L, Mukhtar RA, I-SPY2 Locoregional Working Group
    Ann Surg Oncol. 2025 May; 32(5):3278-3291.; 
    PubMed
  124. Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situ.
    Greenwood HI, Maldonado Rodas CK, Freimanis RI, Glencer AC, Miller PN, Mukhtar RA, Brabham C, Yau C, Rosenbluth JM, Hirst GL, Campbell MJ, Borowsky A, Hylton N, Esserman LJ, Basu A
    NPJ Breast Cancer. 2024 Aug 04; 10(1):71.; 
    PubMed
  125. UCSF Research Profile ">Impact of extent of disease at presentation on oncologic outcomes according to pathologic response to neoadjuvant systemic therapy among participants of the I-SPY2 clinical trial.
    Roberto Antonio Leon-Ferre, Katrina Dimitroff, Christina Yau, Karthik Giridhar, Rita A. Mukhtar, Gillian L. Hirst, Nola Hylton, W. Fraser Fraser Symmans, Matthew P. Goetz, Laura Esserman, Judy Caroline Boughey
    Journal of Clinical Oncology. 2024 Jun 1; 42(16_suppl):594-594.; 
    UCSF Research Profile ">UCSF Research Profile
  126. UCSF Research Profile ">Abstract PO5-26-07: Surgery for Invasive Lobular Carcinoma: A Patient Experience Survey from the Lobular Breast Cancer Alliance.
    Laurie Hutcheson, Janice Axelrod, Tracy Cushing, Colleen Fitzwater, Rinath Jeselsohn, Gitte Joergensen, Maria Karsten, Miranda Kimm, Megan Kruse, Theresa Langdon, Julia Levine, Mason Mitchell-Daniels, Rita Mukhtar, Barbara Neilsen, Shani Paluch-Shimon, Therese Pross
    Cancer Research. 2024 May 2; 84(9_Supplement):po5-26-07-po5-26-07.; 
    UCSF Research Profile ">UCSF Research Profile
  127. Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer.
    Record H, Clelland E, Rothschild HT, Kaur M, Chien AJ, Melisko M, Rugo HS, Mujir F, Huppert L, Mukhtar RA
    NPJ Breast Cancer. 2023 Oct 26; 9(1):88.; 
    PubMed
  128. Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes.
    Kaur M, Patterson A, Molina-Vega J, Rothschild H, Clelland E, Ewing CA, Mujir F, Esserman LJ, Olopade OI, Mukhtar RA
    Cancer Epidemiol Biomarkers Prev. 2023 08 01; 32(8):1107-1113.; 
    PubMed
  129. Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 Trial.
    Mukhtar RA, Chau H, Woriax H, Piltin M, Ahrendt G, Tchou J, Yu H, Ding Q, Dugan CL, Sheade J, Crown A, Carr M, Wong J, Son J, Yang R, Chan T, Terando A, Alvarado M, Ewing C, Tonneson J, Tamirisa N, Gould R, Singh P, Godellas C, Larson K, Chiba A, Rao R, Sauder C, Postlewait L, Lee MC, Symmans WF, Esserman LJ, Boughey JC, ISPY-2 Locoregional Working Group
    Ann Surg. 2023 09 01; 278(3):320-327.; 
    PubMed
  130. UCSF Research Profile ">Abstract P3-09-01: Characterization of residual disease after neoadjuvant selective estrogen receptor degrader (SERD) therapy using tumor organoids in the I-SPY Endocrine Optimization Protocol (EOP).
    Jennifer Rosenbluth, Christopher J. Schwartz, Tam Binh Bui, Shruti Warhadpande, Pravin Phadatare, Sigal Eini, Michael Bruck, Julissa Molina-Vega, Kami Pullakhandam, Nicole Schindler, Lamorna A. Brown Swigart, Christina Yau, Gillian Hirst, Rita Mukhtar, Karthik V. Giridhar, Olufunmilayo I. Olopade, Kevin Kalinsky, Cheryl A. Ewing, Jasmine M. Wong, Michael D. Alvarado, Laura Van’t Veer, Laura J. Esserman, Jo Chien
    Cancer Research. 2023 Mar 1; 83(5_Supplement):p3-09-01-p3-09-01.; 
    UCSF Research Profile ">UCSF Research Profile
  131. Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial.
    Osdoit M, Yau C, Symmans WF, Boughey JC, Ewing CA, Balassanian R, Chen YY, Krings G, Wallace AM, Zare S, Fadare O, Lancaster R, Wei S, Godellas CV, Tang P, Tuttle TM, Klein M, Sahoo S, Hieken TJ, Carter JM, Chen B, Ahrendt G, Tchou J, Feldman M, Tousimis E, Zeck J, Jaskowiak N, Sattar H, Naik AM, Lee MC, Rosa M, Khazai L, Rendi MH, Lang JE, Lu J, Tawfik O, Asare SM, Esserman LJ, Mukhtar RA
    JAMA Surg. 2022 11 01; 157(11):1034-1041.; 
    PubMed
  132. Association of Residual Cancer Burden After Neoadjuvant Therapy and Event-Free Survival in Breast Cancer-Reply.
    Mukhtar R, Symmans WF, Esserman LJ
    JAMA Oncol. 2022 04 01; 8(4):1.; 
    PubMed
  133. UCSF Research Profile ">O13 BIOLOGIC VERSUS SYNTHETIC MESH IN VENTRAL HERNIA REPAIR: PARTICIPANT-LEVEL ANALYSIS OF TWO RANDOMIZED CONTROLLED TRIALS AT ONE YEAR.
    Naila Dhanani, Oscar Olavarria, Kyung Hyun Lee, Charlotte Young, Frank Primus, Rita Mukhtar, Julie Holihan, Mike Liang, Hobart Harris
    British Journal of Surgery. 2021 Nov 24; 108(Supplement_8).; 
    UCSF Research Profile ">UCSF Research Profile
  134. Relationship between body mass index and malignancy rates of MRI-guided breast biopsies: impact of clinicodemographic factors.
    Tang A, Cohan CM, Hansen KS, Beattie G, Greenwood HI, Mukhtar RA
    Breast Cancer Res Treat. 2021 Aug; 188(3):739-747.; 
    PubMed
  135. Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
    Scheepens JCC, Veer LV', Esserman L, Belkora J, Mukhtar RA
    Breast. 2021 Apr; 56:61-69.; 
    PubMed
  136. Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater.
    Abel MK, Brabham CE, Guo R, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Mukhtar RA
    PubMed
  137. UCSF Research Profile ">Abstract P5-08-05: Risk of subsequent events after initial diagnosis of ductal carcinoma in situ - A large multi-center registry study.
    Thomas O'Keefe, Christina Yau, Eliza Jeong, Emma Iaconetti, Paul Kim, Ann Griffin, Joseph McGuire, Rita Mukhtar, Laura Esserman, Olivier Harismendy, Gillian L. Hirst
    Cancer Research. 2020 Feb 15; 80(4_Supplement):p5-08-05-p5-08-05.; 
    UCSF Research Profile ">UCSF Research Profile
  138. Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.
    Jones EF, Ray KM, Li W, Chien AJ, Mukhtar RA, Esserman LJ, Franc BL, Seo Y, Pampaloni MH, Joe BN, Hylton NM
    NPJ Breast Cancer. 2019; 5:12.; 
    PubMed
  139. Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
    Boughey JC, Alvarado MD, Lancaster RB, Symmans WF, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Goodellas C, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ, I-SPY2 Investigators
    NPJ Breast Cancer. 2019; 5:2.; 
    PubMed
  140. UCSF Research Profile ">Abstract P5-22-22: Breast tumor location in BRCA mutation carriers and implications for prevention.
    A Hosseini, LJ Esserman, AM Wallace, A Au, RA Mukhtar
    Poster Session Abstracts. 2018 Feb 15; p5-22-22-p5-22-22.; 
    UCSF Research Profile ">UCSF Research Profile
  141. The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context.
    Campbell MJ, Wolf D, Mukhtar RA, Tandon V, Yau C, Au A, Baehner F, van't Veer L, Berry D, Esserman LJ
    PLoS One. 2013; 8(10):e79114.; 
    PubMed
  142. Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity.
    Mukhtar RA, Moore AP, Nseyo O, Baehner FL, Au A, Moore DH, Twomey P, Campbell MJ, Esserman LJ
    Breast Cancer Res Treat. 2011 Nov; 130(2):635-44.; 
    PubMed
  143. Benign thoracic disease in the elderly.
    Mukhtar RA, Theodore PR
    Thorac Surg Clin. 2009 Aug; 19(3):313-9.; 
    PubMed
  144. ASO Visual Abstract: Omission of Axillary Surgery in Patients with Invasive Lobular Carcinoma of the Breast-Rates of Nodal Involvement in Clinically Node-Negative Patients and Impact on Recurrence in a Single-Institution Analysis.
    Abeles E, Shui AM, Quirarte A, Barkin J, Choi S, Chen Y, Huppert L, Kim N, Moya J, Vertido A, Mukhtar RA
    Ann Surg Oncol. 2026 Oct; 33(11):9791-9792.; 
    PubMed
  145. Omission of Axillary Surgery in Patients with Invasive Lobular Carcinoma of the Breast: Rates of Nodal Involvement in Clinically Node Negative Patients and Impact on Recurrence in a Single Institution Analysis.
    Abeles E, Shui AM, Quirarte A, Barkin J, Choi S, Chen Y, Huppert L, Kim N, Moya J, Vertido A, Mukhtar RA
    Ann Surg Oncol. 2026 Oct; 33(11):9781-9790.; 
    PubMed
  146. Cryoablation Versus Breast-Conserving Surgery for Early-Stage, Low-Risk Breast Cancer ≤ 1.5 cm: A Cost-Effectiveness Analysis.
    Wu X, Kolli KP, Mukhtar RA, Chung M, Joe BN, Kohlbrenner RM
    PubMed
  147. Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
    Mukhtar RA, Dimitroff K, Yau C, Chien AJ, Connolly EP, Howard-McNatt M, Rao R, Ladores V, Golshan M, Sauder CA, Ahmed K, Lancaster R, Fox J, Gutnik L, Lee MC, Tchou J, Prionas N, Arciero CA, Reyna C, Kuerer H, Switalla K, Taunk N, Tuttle TM, Moran MS, Postlewait LM, Perlmutter J, DeMichele A, Yee D, Hylton N, Symmans WF, Rugo HS, Shatsky R, Isaacs C, Esserman LJ, Van't Veer L, Boughey JC
    Ann Surg Oncol. 2025 Oct; 32(11):8243-8253.; 
    PubMed
  148. UCSF Research Profile ">Breast cancer diagnosis, management, and outcomes in transgender, nonbinary, and gender-diverse individuals: A multicenter cohort.
    Chandler Scott Cortina, Ruta Brazauskas, Meghan Rose Flanagan, Kathie-Ann P. Joseph, Rita Mukhtar, Olga Kantor, Kristen M. Rezak, Laura Horst Rosenberger, Sumanas Jordan, Rachel Jimenez, Katherine A. Kopkash, Tasha Hughes, Meeghan A. Lautner, Emily L. Siegel, Zahraa Alhilli, Michael Ryan Cassidy, Rachel L. McCaffrey, Marie Catherine Lee, Anna Weiss, Melinda Stolley
    Journal of Clinical Oncology. 2025 Jun 1; 43(16_suppl):1516-1516.; 
    UCSF Research Profile ">UCSF Research Profile
  149. Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype: A Systematic Review and Meta-analysis Evaluating the Impact of Oncoplastic Surgery.
    Switalla KM, Falade IO, Quirarte A, Baxter M, Kaur M, Sakr RA, Corso G, Mukhtar RA
    Ann Surg Oncol. 2025 Jul; 32(7):4899-4909.; 
    PubMed
  150. Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy.
    Jacob S, Christofferson A, Fisch S, Norwood P, Castillo P, Yu H, Hirst G, Soliman H, Nanda R, Mukhtar RA, Ewing C, Majure M, Melisko M, Rugo HS, Esserman L, Price E, Chien AJ
    Breast Cancer Res Treat. 2025 Jan; 209(1):147-159.; 
    PubMed
  151. International survey on invasive lobular breast cancer identifies priority research questions.
    Oesterreich S, Pate L, Lee AV, Chen F, Jankowitz RC, Mukhtar R, Metzger O, Sikora MJ, Li CI, Sotiriou C, Shah OS, Koorman T, Ulaner G, Reis-Filho JS, Davidson NM, Van Baelen K, Hutcheson L, Freeney S, Migyanka F, Turner C, Derksen P, Bear T, Desmedt C
    NPJ Breast Cancer. 2024 Jul 20; 10(1):61.; 
    PubMed
  152. The Neoadjuvant Approach to Treatment of Breast Cancer: Multidisciplinary Management to Improve Outcomes.
    Baskin AS, Huppert LA, Kelil T, Singer L, Mukhtar RA
    Surg Oncol Insight. 2024 Jun; 1(2).; 
    PubMed
  153. Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma.
    Chen JJ, Zhu I, Patel A, Krings G, Chen YY, Yuen F, Mukhtar RA, Melisko M, Singer L, Park CC, Prionas ND
    Adv Radiat Oncol. 2024 May; 9(5):101448.; 
    PubMed
  154. UCSF Research Profile ">356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study.
    S. Gottipati, H.M. Earl, C. Yau, D.A. Cameron, J. Abraham, L. Hayward, F. Reyal, M. Osdoit, G.S. Sonke, J. Wesseling, J. Boughey, M.P. Goetz, A. DeMichele, L. Pusztai, P. Sharma, M. Martin Jimenez, S. Lopez-Tarruella Cobo, M. Del Monte-Millan, F. Symmans, R. Mukhtar
    Annals of Oncology. 2023 Oct 1; 34:s325-s326.; 
    UCSF Research Profile ">UCSF Research Profile
  155. Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.
    Rothschild HT, Clelland EN, Mujir F, Record H, Wong J, Esserman LJ, Alvarado M, Ewing C, Mukhtar RA
    Ann Surg Oncol. 2023 Oct; 30(10):5999-6006.; 
    PubMed
  156. UCSF Research Profile ">407 Moving from observational studies to a clinical trial: the impact of obesity and surgical weight loss on breast imaging, tissue, and cancer screening experience: the B-BRITE study.
    Elle N Clelland, Judy Gonzalez-Vargas, Sarah G Palilla, Suneil K Koliwad, Heather I Greenwood, Christopher J Schwartz, Chris C. Benz, Diana L Alba, Rita A Mukhtar
    Journal of Clinical and Translational Science. 2023 Apr 24; 7(s1):121-122.; 
    UCSF Research Profile ">UCSF Research Profile
  157. Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior.
    Schwartz CJ, Ruiz J, Bean GR, Sirohi D, Joseph NM, Hosfield EM, Jacobs TW, Mukhtar RA, Chen YY, Krings G
    Mod Pathol. 2023 05; 36(5):100125.; 
    PubMed
  158. UCSF Research Profile ">See one, do one, teach one: a flipped classroom to make quality improvement experiential in surgical residency.
    Tasce Bongiovanni, Elizabeth Lancaster, Hannah Decker, Rita A. Mukhtar, Marisa Schwab, Jeanette Broering, Patricia O’Sullivan, Kenzo Hirose, Elizabeth Wick
    Global Surgical Education - Journal of the Association for Surgical Education. 2022 Aug 25; 1(1):36.; 
    UCSF Research Profile ">UCSF Research Profile
  159. UCSF Research Profile ">Abstract P2-02-02: Differences in levels of circulating tumor cells (CTC) and disseminated tumor cells (DTC) in early-stage lobular versus ductal breast cancer.
    Silver Alkhafaji, Denise Wolf, Mark Magbanua, Laura Van 't Veer, John Park, Laura J. Esserman, Rita A. Mukhtar
    Cancer Research. 2022 Feb 15; 82(4_Supplement):p2-02-02-p2-02-02.; 
    UCSF Research Profile ">UCSF Research Profile
  160. Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
    Yee D, Isaacs C, Wolf DM, Yau C, Haluska P, Giridhar KV, Forero-Torres A, Jo Chien A, Wallace AM, Pusztai L, Albain KS, Ellis ED, Beckwith H, Haley BB, Elias AD, Boughey JC, Kemmer K, Yung RL, Pohlmann PR, Tripathy D, Clark AS, Han HS, Nanda R, Khan QJ, Edmiston KK, Petricoin EF, Stringer-Reasor E, Falkson CI, Majure M, Mukhtar RA, Helsten TL, Moulder SL, Robinson PA, Wulfkuhle JD, Brown-Swigart L, Buxton M, Clennell JL, Paoloni M, Sanil A, Berry S, Asare SM, Wilson A, Hirst GL, Singhrao R, Asare AL, Matthews JB, Hylton NM, DeMichele A, Melisko M, Perlmutter J, Rugo HS, Fraser Symmans W, Van't Veer LJ, Berry DA, Esserman LJ
    NPJ Breast Cancer. 2021 Oct 05; 7(1):131.; 
    PubMed
  161. Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma.
    Abel MK, Greenwood H, Kelil T, Guo R, Brabham C, Hylton N, Wong J, Alvarado M, Ewing C, Esserman LJ, Boughey JC, Mukhtar RA
    NPJ Breast Cancer. 2021 Mar 05; 7(1):25.; 
    PubMed
  162. Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast: Factors associated with false negatives.
    Mukhtar RA, Brabham CE, Guo R, Abel MK, Wong J, Ewing C, Esserman LJ, Alvarado M
    Breast J. 2021 04; 27(4):406-408.; 
    PubMed
  163. UCSF Research Profile ">Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast.
    Ruby Guo, Case E. Brabham, Kelly Fahrner-Scott, Mary Kathryn Abel, Jasmine Wong, Michael Alvarado, Laura Esserman, Cheryl Ann Ewing, Rita A. Mukhtar
    Journal of Clinical Oncology. 2020 May 20; 38(15_suppl):e12604-e12604.; 
    UCSF Research Profile ">UCSF Research Profile
  164. UCSF Research Profile ">Pragmatic Trials and Approaches to Transforming Care.
    Peter G. Stock, Rita Mukhtar, Hila Ghersin, Allison Stover Fiscalini, Laura Esserman
    . 2020 Jan 1; 59-76.; 
    UCSF Research Profile ">UCSF Research Profile
  165. Changes in mammographic density following bariatric surgery.
    Hosseini A, Khoury AL, Varghese F, Carter J, Wong JM, Mukhtar RA
    Surg Obes Relat Dis. 2019 Jun; 15(6):964-968.; 
    PubMed
  166. Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
    Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ, and I-SPY 2 Investigators
    NPJ Breast Cancer. 2018; 4:26.; 
    PubMed
  167. The Novel Application of Genomic Profiling Assays to Shorten Inactive Status for Potential Kidney Transplant Recipients With Breast Cancer.
    Mukhtar RA, Piper ML, Freise C, Van't Veer LJ, Baehner FL, Esserman LJ
    Am J Transplant. 2017 01; 17(1):292-295.; 
    PubMed
  168. Biology of breast cancer in Nigerian women: a pilot study.
    Adisa CA, Eleweke N, Alfred AA, Campbell MJ, Sharma R, Nseyo O, Tandon V, Mukhtar R, Greninger A, Risi JD, Esserman LJ
    Ann Afr Med. 2012 Jul-Sep; 11(3):169-75.; 
    PubMed
  169. Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics.
    Mukhtar RA, Nseyo O, Campbell MJ, Esserman LJ
    Expert Rev Mol Diagn. 2011 Jan; 11(1):91-100.; 
    PubMed
  170. Quality-of-life issues in psoriasis.
    Mukhtar R, Choi J, Koo JY
    Dermatol Clin. 2004 Oct; 22(4):389-95, viii.; 
    PubMed
  171. Correction: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.
    Tseng J, Dimitroff K, Sauder CAM, Chien AJ, Ahmed KA, Allen LF, Arciero CA, Burke EE, Chandler JM, Jordan JE, Golshan M, Gutnik LA, Jaskowiak NT, Hewitt KC, Howard-McNatt M, Ito F, Kang IM, Kesmodel SB, Kuerer HM, Lee MC, Moran MS, Postlewait LM, Prionas ND, Rao R, Reyna CR, Schwer A, Taunk NK, Tchou J, Wallace AM, Li TJ, Perlmutter J, DeMichele AM, Yee D, Hylton NM, Veer LJV, Rugo HS, Symmans WF, Shatsky RA, Isaacs CJD, Yau C, Esserman LJ, Boughey JC, Mukhtar RA
    Ann Surg Oncol. 2026 Sep 03.; 
    PubMed
  172. Tailoring Management for Invasive Lobular Carcinoma: Imaging, Surgical Treatment, and Systemic Therapy Considerations.
    Mukhtar RA, Covington MF, Fanucci K, Jeselsohn R
    Am Soc Clin Oncol Educ Book. 2026 Mar; 46(3):e520848.; 
    PubMed
  173. Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial.
    Van Hassel J, Dimitroff K, Yau C, Mukhtar R, Boughey JC, Ladores V, Howard-McNatt MM, Jaskowiak N, Perlmutter J, DeMichele A, Yee D, Hylton N, Symmans WF, Veer LV, Rugo H, Esserman LJ, Shatsky R, Isaacs C, Kuerer H, Wallace AM, Prionas N, Tseng J, Reyna CR, Taunk N, Kesmodel S, Lee MC, Fox J, Piltin MA, Tchou J, Arciero CA, Postlewait LM, Sauder C, Rao R
    PubMed
  174. ASO Author Reflections: Accuracy of MRI in Invasive Lobular Carcinoma after Neoadjuvant Therapy: Impact of Non-mass Enhancement.
    Vertido A, Mukhtar RA
    Ann Surg Oncol. 2025 Jul 10.; 
    PubMed
  175. UCSF Research Profile ">Patient experiences of diagnosis and treatment of invasive lobular carcinoma: A qualitative study from a prospective registry.
    Astrid Quirarte, Anna Lannhi Vertido, Sophia Zamudio-Haas, Jo Chien, Rita Mukhtar
    Journal of Clinical Oncology. 2025 Jun 1; 43(16_suppl):11111-11111.; 
    UCSF Research Profile ">UCSF Research Profile
  176. UCSF Research Profile ">Abstract No. 239 Cryoablation Versus Breast-Conserving Surgery for Early-Stage, Low-Risk Breast Cancer = 1.5 cm: A Cost-Effectiveness Analysis.
    X. Wu, K. Kolli, R. Mukhtar, B. Joe, R. Kohlbrenner
    Journal of Vascular and Interventional Radiology. 2025 Mar 1; 36(3):s110.; 
    UCSF Research Profile ">UCSF Research Profile
  177. UCSF Research Profile ">Therapeutic response and outcomes with uncommon breast cancer subtypes in the I-SPY trial 2010-2022.
    Alexandra Thomas, Denise M. Wolf, Ronald Balassanian, Yunn-Yi Chen, Julia Ye, Poonam Vohra, Evin H. Gulbahce, Alexander D. Borowsky, Lamorna Brown Swigart, Gillian L. Hirst, Sara Venters, Rita Nanda, Rebecca Arielle Shatsky, Ralph D'Agostino, Rita A. Mukhtar, Sarah Hatcher, Christina Yau, Angela DeMichele, Laura van 't Veer, Laura Esserman
    Journal of Clinical Oncology. 2024 Aug 10; 42(23_suppl):1-1.; 
    UCSF Research Profile ">UCSF Research Profile
  178. Surveillance Strategies After Primary Treatment for Patients with Invasive Lobular Carcinoma of the Breast: Method of Local Recurrence Detection After Breast-Conserving Surgery.
    Clelland EN, Quirarte A, Rothschild HT, Kaur M, Mujir F, Record H, Wong JM, Mukhtar RA
    Ann Surg Oncol. 2024 Oct; 31(11):7315-7322.; 
    PubMed
  179. Oncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular Carcinoma.
    Falade I, Switalla K, Quirarte A, Baxter M, Soroudi D, Rothschild H, Abe SE, Goodwin K, Piper M, Wong J, Foster R, Mukhtar RA
    Ann Surg Oncol. 2024 Oct; 31(11):7409-7417.; 
    PubMed
  180. Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants.
    Schwartz CJ, Khorsandi N, Blanco A, Mukhtar RA, Chen YY, Krings G
    Breast Cancer Res Treat. 2024 Feb; 204(1):171-179.; 
    PubMed
  181. ASO Author Reflections: Menopausal Status Does Not Predict Successful Breast Conservation Surgery After Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma.
    Ramalingam K, Mukhtar R
    Ann Surg Oncol. 2023 Nov; 30(12):7137-7138.; 
    PubMed
  182. Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.
    Boughey JC, Yu H, Dugan CL, Piltin MA, Postlewait L, Son JD, Edmiston KK, Godellas CV, Lee MC, Carr MJ, Tonneson JE, Crown A, Lancaster RB, Woriax HE, Ewing CA, Chau HS, Patterson AK, Wong JM, Alvarado MD, Yang RL, Chan TW, Sheade JB, Ahrendt GM, Larson KE, Switalla K, Tuttle TM, Tchou JC, Rao R, Tamirisa N, Singh P, Gould RE, Terando A, Sauder C, Hewitt K, Chiba A, Esserman LJ, Mukhtar RA
    Ann Surg Oncol. 2023 Oct; 30(11):6401-6410.; 
    PubMed
  183. UCSF Research Profile ">Abstract HER2-14: HER2-14 HER-2 low status in early stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.
    Harriet T. Rothschild, Elle Clelland, Anne Patterson, Julissa Molina-Vega, Mandeep Kaur, Mary Kathryn Abel, W. Fraser Symmans, Christopher J. Schwartz, Rita Mukhtar
    Cancer Research. 2023 Mar 1; 83(5_Supplement):her2-14-her2-14.; 
    UCSF Research Profile ">UCSF Research Profile
  184. Implementation, evaluation, and modification of a near-peer learning group in graduate surgical education.
    Conroy PC, Mohamedaly S, Karimzada M, Brian R, Im C, Hernandez S, Roman S, Hirose K, Mukhtar R, Kirkwood K, O'Sullivan P, Alseidi A
    Am J Surg. 2023 03; 225(3):591-592.; 
    PubMed
  185. UCSF Research Profile ">Abstract LB021: Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer progression.
    Jason J. Northey, Yoshihiro Yui, Mary-Kate Hayward, Connor Stashko, FuiBoon Kai, Janna Mouw, Dhruv Thakar, Jonathon Lakins, Alastair Ironside, Susan Samson, Rita Mukhtar, E. Shelley Hwang, Valerie Weaver
    Cancer Research. 2022 Jun 15; 82(12_Supplement):lb021-lb021.; 
    UCSF Research Profile ">UCSF Research Profile
  186. UCSF Research Profile ">Abstract P3-03-07: Single-institution retrospective analysis of lymph node (LN) change on breast MRI in patients with high risk early-stage breast cancer receiving neoadjuvant chemotherapy with and without immunotherapy on the ISPY-2 TRIAL.
    Anika Christofferson, Elissa Price, Rita A Mukhtar, Amrita Basu, Laura Esserman, A Jo Chien
    Cancer Research. 2022 Feb 15; 82(4_Supplement):p3-03-07-p3-03-07.; 
    UCSF Research Profile ">UCSF Research Profile
  187. Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: Incidence and management strategies.
    Hewitt KC, Miller P, Piper M, Prionas N, Son JD, Alvarado M, Esserman LJ, Wong JM, Ewing C, Mukhtar RA
    Am J Surg. 2022 04; 223(4):699-704.; 
    PubMed
  188. UCSF Research Profile ">Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions.
    Rita A. Mukhtar, A. Jo Chien
    Current Breast Cancer Reports. 2021 Apr 12; 1-7.; 
    UCSF Research Profile ">UCSF Research Profile
  189. UCSF Research Profile ">Abstract PS1-03: Active surveillance for DCIS: Clinical outcomes at 5.6 years mean follow-up.
    Case Brabham, Rita Mukhtar, April Liang, Paul Kim, Gillian Hirst, Amrita Basu, Heather Greenwood, Rita Freimanis, Alexander Borowsky, Shelley Hwang, Rick Baehner, Gregor Krings, Nola Hylton, Laura Esserman
    Cancer Research. 2021 Feb 15; 81(4_Supplement):ps1-03-ps1-03.; 
    UCSF Research Profile ">UCSF Research Profile
  190. UCSF Research Profile ">274 Poster Unintended bias in clinical trials: The prevalence of entry criteria that exclude patients with invasive lobular carcinoma from metastatic breast cancer trials.
    M.K. Abel, I. Diaz, J. Levine, L. Pate, E. Viggiano, M. Melisko, R. Mukhtar
    European Journal of Cancer. 2020 Oct 1; 138:s69-s70.; 
    UCSF Research Profile ">UCSF Research Profile
  191. UCSF Research Profile ">Abstract P3-08-16: The impact of residual ductal carcinoma in situ on breast cancer recurrence in the neoadjuvant I-SPY2 TRIAL.
    Marie Osdoit, Christina Yau, W. Fraser Symmans, Judy C. Boughey, Smita M. Asare, Ron Balassanian, Jodi M. Carter, Yunn-Yi Chen, Kimberly Cole, Laila Khazai, Molly Klein, Dina Kokh, Gregor Krings, Sunati Sahoo, Gretchen Ahrendt, Akiko Chiba, Cheryl Ewing, Constantine Godellas, Nora Jaskowiak, Brigid Killelea, Helen Krontiras, Rachael Lancaster, Julie Lang, M. Catherine Lee, Arpana Naik, Roshni Rao, Julia Tchou, Shannon Tierney, Eleni Tousimis, Tod Tuttle, Anne Wallace, Bev Parker, Laura J. Esserman, Rita A. Mukhtar
    Cancer Research. 2020 Feb 15; 80(4_Supplement):p3-08-16-p3-08-16.; 
    UCSF Research Profile ">UCSF Research Profile
  192. Editorial: Applying Margin Consensus Guidelines to Invasive Lobular Carcinoma of the Breast.
    Mukhtar RA
    Ann Surg Oncol. 2019 Nov; 26(12):3798-3799.; 
    PubMed
  193. UCSF Research Profile ">Abstract P6-01-04: Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.
    EF Jones, KM Ray, R Mukhtar, W Li, BL Franc, LJ Esserman, BN Joe, MH Pampaloni, NM Hylton
    Poster Session Abstracts. 2019 Feb 15; p6-01-04-p6-01-04.; 
    UCSF Research Profile ">UCSF Research Profile
  194. UCSF Research Profile ">Abstract P2-12-16: The use of oncoplastic surgical techniques to increase successful breast conservation in invasive lobular carcinoma of the breast.
    JM Wong, ML Piper, C Ewing, M Alvarado, LJ Esserman, H Sbitany, RD Foster, RA Mukhtar
    Poster Session Abstracts. 2018 Feb 15; p2-12-16-p2-12-16.; 
    UCSF Research Profile ">UCSF Research Profile
  195. UCSF Research Profile ">Abstract PD1-5: Characterizing the Tumor Immune MicroEnvironment (TIME) in high-risk ductal carcinoma in situ.
    Michael J Campbell, Rita Mukhtar, Ekene Obi-Okoye, Booyeon Han, Vickram Tandon, Sarah Zheng, Zelos Zhu, Max Endicott, Max Wicha, Linda Lindstrom, Alfred Au, Frederick Baehner, Joe Gray, Laura Esserman
    Poster Discussion Abstracts. 2015 May 1; pd1-5-pd1-5.; 
    UCSF Research Profile ">UCSF Research Profile
  196. UCSF Research Profile ">P4-09-19: PCNA+ Tumor Associated Macrophages Are Associated with M1 and M2 Gene Expression, and Confer Poor Prognosis in the Absence of Anti-Tumor Immune Environment.
    R Mukhtar, D Wolf, V Tandon, J Zhu, M Lenburg, Veer L van't, MJ Campbell
    Poster Session Abstracts. 2011 Dec 15; p4-09-19-p4-09-19.; 
    UCSF Research Profile ">UCSF Research Profile
  197. Long-term survival and renal transplantation in a monozygotic twin with cloacal dysgenesis sequence.
    Mukhtar RA, Baskin LS, Stock PG, Lee H
    J Pediatr Surg. 2009 Dec; 44(12):e31-3.; 
    PubMed
  198. Circulating tumor DNA concentration at diagnosis is a modifiable prognostic factor for distant metastatic recurrence in patients with high-risk breast cancer receiving neoadjuvant therapy.
    Magbanua MJM, Wolf DM, Yau C, Manon NA, Sayaman RW, Brown Swigart L, Hirst G, Li W, Isaacs C, Shatsky R, Clark AS, Zimmer A, Mukhtar R, Delson AL, Perlmutter J, Pohlmann PR, Hylton NM, Nanda R, Yee D, Symmans WF, Esserman LJ, Rugo HS, DeMichele A, van 't Veer LJ
    medRxiv. 2026 Jul 29.; 
    PubMed
  199. Locoregional Considerations for Invasive Lobular Carcinoma.
    Mukhtar RA, Flanagan MR
    Curr Breast Cancer Rep. 2026; 18(1):2.; 
    PubMed
  200. ASO Author Reflections: Equity in the Surgical Management of the Axilla.
    Kaur M, Boughey JC, Mukhtar RA
    Ann Surg Oncol. 2025 Oct; 32(11):8220-8221.; 
    PubMed
  201. Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial.
    Leon-Ferre RA, Dimitroff K, Yau C, Giridhar KV, Mukhtar R, Hirst G, Hylton N, Perlmutter J, DeMichele A, Yee D, van 't Veer L, Rugo H, Symmans WF, Goetz MP, Esserman L, Boughey JC
    Breast Cancer Res. 2025 Jun 23; 27(1):115.; 
    PubMed
  202. UCSF Research Profile ">Predicting nodal burden after neoadjuvant chemotherapy (NAC) with circulating tumor (ct)DNA for surgical planning: Results from the I-SPY2 trial.
    Rita Mukhtar, Katrina Dimitroff, Christina Yau, Laura van t Veer, Jo Chien, Gillian L. Hirst, Lamorna Brown Swigart, Angela DeMichele, Douglas Yee, Hope S. Rugo, Rebecca Arielle Shatsky, Claudine Isaacs, Kamran A. Ahmed, Julia C. Tchou, Henry Mark Kuerer, Chantal Reyna, Candice A. Sauder, Laura Esserman, Judy Caroline Boughey, Mark Jesus M. Magbanua
    Journal of Clinical Oncology. 2025 May 28; 43(16_suppl):504-504.; 
    UCSF Research Profile ">UCSF Research Profile
  203. Tumor Morphology for Prediction of Poor Responses Early in Neoadjuvant Chemotherapy for Breast Cancer: A Multicenter Retrospective Study.
    Li W, Le NN, Nadkarni R, Onishi N, Wilmes LJ, Gibbs JE, Price ER, Joe BN, Mukhtar RA, Gennatas ED, Kornak J, Magbanua MJM, Van't Veer LJ, LeStage B, Esserman LJ, Hylton NM
    Tomography. 2024 11 20; 10(11):1832-1845.; 
    PubMed
  204. ASO Author Reflections: Evolving Paradigms in Axillary Management for Breast Cancer: Insights from the ISPY-2 Neoadjuvant Chemotherapy Trial.
    Switalla KM, Boughey JC, Mukhtar RA
    Ann Surg Oncol. 2024 Oct; 31(11):7260-7261.; 
    PubMed
  205. UCSF Research Profile ">Therapeutic response and outcomes with less common breast cancer subtypes in the I-SPY trial 2011-2022.
    Alexandra Thomas, Denise M. Wolf, Ronald Balassanian, Yunn-Yi Chen, Julia Ye, Poonam Vohra, Evin H Gulbahce, Alexander D. Borowsky, Lamorna Brown Swigart, Gillian L. Hirst, Sara Venters, Rita Nanda, Rebecca Arielle Shatsky, Ralph D'Agostino, Rita A. Mukhtar, Sarah Hatcher, Christina Yau, Angela DeMichele, Laura van 't Veer, Laura Esserman
    Journal of Clinical Oncology. 2024 Jun 1; 42(16_suppl):582-582.; 
    UCSF Research Profile ">UCSF Research Profile
  206. Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis.
    Alkhafaji S, Wolf DM, Magbanua MJM, J van 't Veer L, Park JW, Esserman L, Mukhtar RA
    NPJ Breast Cancer. 2024 Feb 26; 10(1):17.; 
    PubMed
  207. Letter to the Editor of Annals of Surgical Oncology concerning "Is Choosing Wisely Wise for Lobular Carcinoma in Patients over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns".
    Mukhtar RA, Huppert L, Ramalingam K
    PubMed
  208. Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes.
    Clelland EN, Rothschild HT, Patterson A, Molina-Vega J, Kaur M, Symmans WF, Schwartz CJ, Chien AJ, Benz CC, Mukhtar RA
    Breast Cancer Res Treat. 2023 Nov; 202(2):367-375.; 
    PubMed
  209. Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant Therapy-Reply.
    Mukhtar RA, Yau C, Esserman LJ
    JAMA Surg. 2023 06 01; 158(6):675.; 
    PubMed
  210. UCSF Research Profile ">Abstract P6-05-10: An international survey on invasive lobular breast cancer (ILC) reveals gaps in knowledge and top priority research areas.
    Steffi Oesterreich, Leigh Pate, ADRIAN V. LEE, Rachel C. Jankowitz, Patrick Derksen, Rita Mukhtar, Otto Metzger, Matthew J. Sikora, Christopher Li, Christos Sotiriou, Gary Ulaner, Jorge Reis-Filho, Nancy E Davidson, Karen Van Baelen, Laurie Hutcheson, Siobhan Freeney, Flora Migyanka, Claire Turner, Todd Bear, Christine Desmedt
    Cancer Research. 2023 Mar 1; 83(5_Supplement):p6-05-10-p6-05-10.; 
    UCSF Research Profile ">UCSF Research Profile
  211. UCSF Research Profile ">Hereditary vs Sporadic Invasive Lobular Carcinoma and Impact of Locoregional Therapy on Disease-Free Survival.
    Alison S Baskin, Anne K Patterson, Amie M Blanco, Julie S Mak, Rita A Mukhtar
    Journal of the American College of Surgeons. 2022 Oct 17; 235(5):s34-s34.; 
    UCSF Research Profile ">UCSF Research Profile
  212. Emotional Regulation in Surgery: Fostering Well-Being, Performance, and Leadership.
    Greenberg AL, Sullins VF, Donahue TR, Sundaram VM, Saldinger PF, Divino CM, Anton NE, Stefanidis D, Reilly LM, Egan RJ, Beals CKJ, Riall TS, Duh QY, Mukhtar RA, Hirose K, Lebares CC
    J Surg Res. 2022 09; 277:A25-A35.; 
    PubMed
  213. Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer.
    Rothschild HT, Abel MK, Patterson A, Goodman K, Shui A, van Baelen K, Desmedt C, Benz C, Mukhtar RA
    Breast Cancer Res Treat. 2022 Jan; 191(2):451-458.; 
    PubMed